The HogenEsch Research Group

Our research focuses on vaccine development and mechanisms of chronic inflammation for the benefit of people and animals.

Recent Publications

Franco J, Rajwa B, Ferreira C, Sundberg JP, HogenEsch H (2020) Influence of sex and disease stage on epidermal lipid profiles in SHARPIN-deficient mice. Metabolites, 10:299.

Hernandez-Franco J, Mosley YC, Franco J, Ragland D, Yao Y, HogenEsch H (2021) Effective and safe stimulation of humoral and cell-mediated immunity by intradermal immunization with a cyclic dinucleotide/nanoparticle combination adjuvant. J Immunol, 206: 700-711.

Mosley YC, Radder JE, HogenEsch H (2019) Genetic variation in the magnitude and longevity of the IgG subclass response to a Diphtheria-Tetanus-acellular Pertussis (DTaP) vaccine in mice. Vaccines, 7:124.

Lu F, Mosley YC, Brown D, Carmichael B, HogenEsch H (2019) Formulation of aluminum hydroxide adjuvant with TLR agonists poly(I:C) and CpG enhances the magnitude and avidity of the humoral immune response. Vaccine, 37:1945-1953. 

Purdue University College of Veterinary Medicine, 625 Harrison Street, West Lafayette, IN 47907, (765) 494-7607

© 2021 Purdue University | An equal access/equal opportunity university | Copyright Complaints | Maintained by PVM Web Communications

If you have trouble accessing this page because of a disability, please contact PVM Web Communications at